Hematological remission and long term hematological control of acute myeloblastic leukemia induced and maintained by granulocyte-colony stimulating factor (G-CSF) therapy.
about
Therapeutic use of granulocyte-colony stimulating factor could conceal residual malignant cells in patients with AML1/ETO+ acute myelogenous leukemia.Mathematical modeling of the impact of cytokine response of acute myeloid leukemia cells on patient prognosis.Prophylactic use of granulocyte colony-stimulating factor after induction chemotherapy in patients with newly diagnosed acute myeloid leukemia may increase the complete remission rate: a meta-analysis of five randomised controlled trials.
P2860
Hematological remission and long term hematological control of acute myeloblastic leukemia induced and maintained by granulocyte-colony stimulating factor (G-CSF) therapy.
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Hematological remission and lo ...... lating factor (G-CSF) therapy.
@ast
Hematological remission and lo ...... lating factor (G-CSF) therapy.
@en
type
label
Hematological remission and lo ...... lating factor (G-CSF) therapy.
@ast
Hematological remission and lo ...... lating factor (G-CSF) therapy.
@en
prefLabel
Hematological remission and lo ...... lating factor (G-CSF) therapy.
@ast
Hematological remission and lo ...... lating factor (G-CSF) therapy.
@en
P2093
P2860
P1433
P1476
Hematological remission and lo ...... lating factor (G-CSF) therapy.
@en
P2093
António Carlos Pinto Ribeiro
Cristina Gonçalves
Jorge Coutinho
Luciana Xavier
Manuel Cunha
Maria dos Anjos Teixeira
P2860
P304
P356
10.1080/1042819031000111053
P577
2003-12-01T00:00:00Z